RE:RE:RE:RE:RE:Philippe Dubuc, chef de la direction financière de Theratechjfm1330 wrote: SPCEO1 wrote: I am sure Luc is indeed ticked off about the lack of reimbursement from Quebec but I don't think he is so resentful as to not pursue approval for Trogarzo in Canada. But it makes economic sense to go first for Europe before turning attention to Canada given the size of the respective markets. Trogarzo will be sold in Canada in early 2020 if I had to guess.
You know we have an expression in french here in Qubec that says you can walk and chew gum at the same time. I really think Tanguay is playing a little game here. That won't last because it would be unethical and he is a very honest guy, but he still wants to get his message across about Egrifta reimbursment.
The organizations that handle reimbursements are not the same as the ones that approve drugs in most juristriction, maybe quebec is odd! There is no obvious connection between the two issues.